Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
The effect on sotrastaurin pharmacokinetics of strong CYP3A inhibition by ketoconazole
British Journal of Clinical Pharmacology, 09/08/09
Kovarik JM et al. – The strong CYP3A4 inhibitor ketoconazole increased sotrastaurin AUC by 4.6–fold. A compensatory reduction in the dose of sotrastaurin is warranted when strong CYP3A4 inhibitors are co–administered.
Related Articles
Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer
Clinical Cancer Research, 11/09/09
Relevance Score: 87%
Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer
BJU International, 11/02/09
Relevance Score: 83%
Paracoccidioidomycosis
Paediatric Respiratory Reviews, 11/10/09
Relevance Score: 80%
Antifungal activity of the aqueous extract of Ilex paraguariensis against Malassezia furfur
Phytotherapy Research, 10/14/09
Relevance Score: 77%
Fesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09
Relevance Score: 77%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
A Conserved Motif in the Membrane Proximal C-Terminal Tail of Human Muscarinic M1 Acetylcholine Receptors Affects Plasma Membrane Expression
Journal of Pharmacology and Experimental Therapeutics, 11/25/09
The Basic Helix-loop-helix Proteins DEC1 and DEC2 Function as Corepressors of Retinoid X Receptors
Molecular Pharmacology, 11/25/09
Control of GluR2 translational initiation by its alternative 3'UTRs
Molecular Pharmacology, 11/25/09
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
Clinical Pharmacokinetics, 11/24/09
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09
Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients
Transplantation Proceedings, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


